This topic contains a solution. Click here to go to the answer

Author Question: Refer to Scenario 1 . Assume this economy could either be at Point B or Point C. From which of these ... (Read 81 times)

APUS57

  • Hero Member
  • *****
  • Posts: 571
Refer to Scenario 1 . Assume this economy could either be at Point B or Point C. From which of these points is it more costly to produce more crabs? Explain your answer.
 
  What will be an ideal response?

Question 2

Tying salaries of top managers to the profits of the firm is a way to reduce the effect of the principal-agent problem.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yifu223

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

It's more costly to produce more crabs from Point C than it is to produce more crabs from Point B. The reason is that as you move up the production possibilities frontier the more crabs you produce the greater the amount of fish the economy will have to give up to produce them. For example from Point B the opportunity cost of producing 15 more crabs is twenty fish. However, if we start from Point C and wish to produce 15 more crabs we have to give up 30 fish.

Answer to Question 2

TRUE





 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library